Cargando…

A pre-specified model based on four kallikrein markers in blood improves predictions of adverse pathology and biochemical recurrence after radical prostatectomy

BACKGROUND: A pre-specified model based on four kallikrein markers in blood, commercially available as 4Kscore, predicts Gleason Grade (GG) 3 + 4 or higher prostate cancer on biopsy. However, sampling error and variation in pathology reporting may miss aggressive disease. METHODS: The 4Kscore was me...

Descripción completa

Detalles Bibliográficos
Autores principales:	Haese, Alexander, Tin, Amy L., Carlsson, Sigrid V., Sjoberg, Daniel D., Pehrke, Dirk, Steuber, Thomas, Huland, Hartwig, Graefen, Markus, Scardino, Peter T., Schlomm, Thorsten, Vickers, Andrew J., Lilja, Hans, Sauter, Guido
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7434907/ https://www.ncbi.nlm.nih.gov/pubmed/32467601 http://dx.doi.org/10.1038/s41416-020-0914-7

Ejemplares similares

Nuclear ELAC2 overexpression is associated with increased hazard for relapse after radical prostatectomy
por: Schroeder, Cornelia, et al.
Publicado: (2019)

Heterogeneity of ERG expression in prostate cancer: a large section mapping study of entire prostatectomy specimens from 125 patients
por: Tsourlakis, Maria-Christina, et al.
Publicado: (2016)

Histopathological results of radical prostatectomy specimen of men younger than 50 years of age at the time of surgery: possible implications for prostate cancer screening programs?
por: Mehring, Gisa, et al.
Publicado: (2023)

Down-Regulation of S100A8 is an Independent Predictor of PSA Recurrence in Prostate Cancer Treated by Radical Prostatectomy()
por: Minner, Sarah, et al.
Publicado: (2019)

Asian-American Race and Urinary Continence After Radical Prostatectomy
por: Hu, Jim C., et al.
Publicado: (2020)

Association of Age With Risk of Adverse Pathological Findings at Radical Prostatectomy in Men With Gleason Score 6 Prostate Cancer
por: Kim, Daniel W., et al.
Publicado: (2020)

Adjuvant Versus Early Salvage Radiation Therapy After Radical Prostatectomy for pN1 Prostate Cancer and the Risk of Death
por: Tilki, Derya, et al.
Publicado: (2022)

Loss of Somatostatin Receptor Subtype 2 in Prostate Cancer Is Linked to an Aggressive Cancer Phenotype, High Tumor Cell Proliferation and Predicts Early Metastatic and Biochemical Relapse
por: Hennigs, Jan K., et al.
Publicado: (2014)

VEGFR-1 Overexpression Identifies a Small Subgroup of Aggressive Prostate Cancers in Patients Treated by Prostatectomy
por: Tsourlakis, Maria Christina, et al.
Publicado: (2015)

Upregulation of centromere protein F is linked to aggressive prostate cancers
por: Göbel, Cosima, et al.
Publicado: (2018)

Radical prostatectomy in patients aged 75 years or older: review of the literature
por: Mandel, Philipp, et al.
Publicado: (2019)

Subcellular Compartmentalization of Survivin is Associated with Biological Aggressiveness and Prognosis in Prostate Cancer
por: Hennigs, Jan K., et al.
Publicado: (2020)

Preoperative exercise interventions to optimize continence outcomes following radical prostatectomy
por: Mungovan, Sean F., et al.
Publicado: (2021)

Predicting High-Grade Cancer at Ten-Core Prostate Biopsy Using Four Kallikrein Markers Measured in Blood in the ProtecT Study
por: Bryant, Richard J., et al.
Publicado: (2015)

Prostate-Specific Antigen Level at the Time of Salvage Therapy After Radical Prostatectomy for Prostate Cancer and the Risk of Death
por: Tilki, Derya, et al.
Publicado: (2023)

HOXB13 overexpression is an independent predictor of early PSA recurrence in prostate cancer treated by radical prostatectomy
por: Zabalza, Cristina Villares, et al.
Publicado: (2015)

Validation study of a web-based assessment of functional recovery after radical prostatectomy
por: Vickers, Andrew J, et al.
Publicado: (2010)

Circulating microRNAs and Kallikreins before and after Radical Prostatectomy: Are They Really Prostate Cancer Markers?
por: Egidi, Maria Giulia, et al.
Publicado: (2013)

Feasibility study of a clinically-integrated randomized trial of modifications to radical prostatectomy
por: Vickers, Andrew J, et al.
Publicado: (2012)

Surgeon heterogeneity significantly affects functional and oncological outcomes after radical prostatectomy in the Swedish LAPPRO trial
por: Nyberg, Martin, et al.
Publicado: (2020)

Up regulation of the Hippo signalling effector YAP1 is linked to early biochemical recurrence in prostate cancers
por: Marx, Andreas, et al.
Publicado: (2020)

A four-kallikrein panel for the prediction of repeat prostate biopsy: data from the European Randomized Study of Prostate Cancer Screening in Rotterdam, Netherlands
por: Gupta, A, et al.
Publicado: (2010)

A panel of kallikrein markers can reduce unnecessary biopsy for prostate cancer: data from the European Randomized Study of Prostate Cancer Screening in Göteborg, Sweden
por: Vickers, Andrew J, et al.
Publicado: (2008)

Influence of blood prostate specific antigen levels at age 60 on benefits and harms of prostate cancer screening: population based cohort study
por: Carlsson, Sigrid, et al.
Publicado: (2014)

Comparing the effect of positioning on cerebral autoregulation during radical prostatectomy: a prospective observational study
por: Beck, Stefanie, et al.
Publicado: (2020)

Cytoreductive radical prostatectomy after chemohormonal therapy in patients with primary metastatic prostate cancer
por: Babst, Christa, et al.
Publicado: (2022)

Primary Tumor Treatment in Oligometastatic Prostate Cancer: Radiotherapy Versus Radical Prostatectomy
por: Knipper, Sophie, et al.
Publicado: (2022)

Outcomes of salvage radical prostatectomy following more than one failed local therapy
por: Sivaraman, Arjun, et al.
Publicado: (2018)

Reduced anoctamin 7 (ANO7) expression is a strong and independent predictor of poor prognosis in prostate cancer
por: Marx, Andreas, et al.
Publicado: (2021)

High mitochondria content is associated with prostate cancer disease progression
por: Grupp, Katharina, et al.
Publicado: (2013)

AB0/Rhesus Blood Group Does Not Influence Clinicopathological Tumor Characteristics or Oncological Outcome in Patients Undergoing Radical Prostatectomy
por: Oh, Su Jung, et al.
Publicado: (2017)

Impact of Sarcopenia on Functional and Oncological Outcomes After Radical Prostatectomy
por: Angerer, Markus, et al.
Publicado: (2021)

Impact of Age on Long-Term Urinary Continence after Robotic-Assisted Radical Prostatectomy
por: Cano Garcia, Cristina, et al.
Publicado: (2023)

Up regulation of Rho-associated coiled-coil containing kinase1 (ROCK1) is associated with genetic instability and poor prognosis in prostate cancer
por: Steurer, Stefan, et al.
Publicado: (2019)

Aberrant expression of the microtubule-associated protein tau is an independent prognostic feature in prostate cancer
por: Schroeder, Cornelia, et al.
Publicado: (2019)

Health-related quality of life and self-reported cognitive function in patients with delayed neurocognitive recovery after radical prostatectomy: a prospective follow-up study
por: Kahl, Ursula, et al.
Publicado: (2021)

Effect of prostatic apex shape (Lee types) and urethral sphincter length in preoperative MRI on very early continence rates after radical prostatectomy
por: Wenzel, Mike, et al.
Publicado: (2021)

Correlation of Urine Loss after Catheter Removal and Early Continence in Men Undergoing Radical Prostatectomy
por: Hoeh, Benedikt, et al.
Publicado: (2021)

A nuclear shift of GSK3β protein is an independent prognostic factor in prostate cancer
por: Eichenauer, Till, et al.
Publicado: (2019)

Loss of cytoplasmic survivin expression is an independent predictor of poor prognosis in radically operated prostate cancer patients
por: Büscheck, Franziska, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ojj0h28h6ad0lgfl9lk9u1np06